Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Propionate and NB-UVB in Active Vitiligo
NCT01246921Phase 4Unknown
- Sponsor
- University of Amsterdam
- Start
- Sep 2009
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of fluticasone propionate nasal spray in nonsegmental vitiligo (NSV), sponsored by University of Amsterdam. Primary endpoint: Repigmentation of the vitiligo lesions at 15 months. Status: unknown.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
nonsegmental vitiligo (NSV)
Beyond the preview
Go deeper on NCT01246921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246921.